300255 常山药业
已收盘 09-11 15:00:00
资讯
新帖
简况
常山药业(300255)股东高树华质押500万股,占总股本0.54%
证券之星 · 09-12 00:18
常山药业(300255)股东高树华质押500万股,占总股本0.54%
常山药业(300255)披露将参加河北辖区上市公司投资者网上集体接待日暨2026年半年报业绩说明会,9月10日股价下跌1.25%
证券之星 · 09-10 22:10
常山药业(300255)披露将参加河北辖区上市公司投资者网上集体接待日暨2026年半年报业绩说明会,9月10日股价下跌1.25%
股市必读:常山药业新发布《第六届董事会第九次会议决议公告》
证券之星 · 09-09
股市必读:常山药业新发布《第六届董事会第九次会议决议公告》
常山药业:艾本那肽减重适应症Ⅰ期临床试验尚未完成首例受试者入组
证券之星 · 09-03
常山药业:艾本那肽减重适应症Ⅰ期临床试验尚未完成首例受试者入组
常山药业(300255)8月31日股东户数6.34万户,较上期减少5.48%
证券之星 · 09-03
常山药业(300255)8月31日股东户数6.34万户,较上期减少5.48%
常山药业:公司正在根据审评要求积极稳步推进艾本那肽(阿贝那肽)的补充资料相关工作
证券之星 · 09-03
常山药业:公司正在根据审评要求积极稳步推进艾本那肽(阿贝那肽)的补充资料相关工作
常山药业:截至2026年8月31日,公司的股东户数为63447户
证券之星 · 09-03
常山药业:截至2026年8月31日,公司的股东户数为63447户
常山药业(300255.SZ)发布上半年业绩,归母净亏损1676.18万元
智通财经网 · 08-25
常山药业(300255.SZ)发布上半年业绩,归母净亏损1676.18万元
常山药业(300255)披露2026年半年度报告及其摘要,8月25日股价上涨3.04%
证券之星 · 08-25
常山药业(300255)披露2026年半年度报告及其摘要,8月25日股价上涨3.04%
图解常山药业中报:第二季度单季净利润同比增长31.15%
证券之星 · 08-25
图解常山药业中报:第二季度单季净利润同比增长31.15%
常山药业(300255)8月20日股东户数6.71万户,较上期减少4.97%
证券之星 · 08-25
常山药业(300255)8月20日股东户数6.71万户,较上期减少4.97%
常山药业(300255)8月20日股东户数6.71万户,较上期减少4.97%
证券之星 · 08-24
常山药业(300255)8月20日股东户数6.71万户,较上期减少4.97%
8月19日常山药业跌5.76%,创业板医药ETF国泰基金重仓该股
证券之星 · 08-19
8月19日常山药业跌5.76%,创业板医药ETF国泰基金重仓该股
常山药业:截至2026年8月10日,公司的股东户数为70629户
证券之星 · 08-13
常山药业:截至2026年8月10日,公司的股东户数为70629户
常山药业:公司正在根据审评要求积极稳步推进艾本那肽(阿贝那肽)的补充资料相关工作
证券之星 · 08-13
常山药业:公司正在根据审评要求积极稳步推进艾本那肽(阿贝那肽)的补充资料相关工作
8月7日常山药业涨8.66%,创业板医药ETF国泰基金重仓该股
证券之星 · 08-07
8月7日常山药业涨8.66%,创业板医药ETF国泰基金重仓该股
常山药业(300255)披露产品拟中选第十二批国家组织药品集中带量采购,8月3日股价上涨1.0%
证券之星 · 08-03
常山药业(300255)披露产品拟中选第十二批国家组织药品集中带量采购,8月3日股价上涨1.0%
常山药业:截至2026年7月31日股东户数为61797户
证券之星 · 08-03
常山药业:截至2026年7月31日股东户数为61797户
常山药业:正在积极推进艾本那肽补充资料工作
证券之星 · 08-03
常山药业:正在积极推进艾本那肽补充资料工作
7月24日常山药业跌7.98%,创业板医药ETF国泰基金重仓该股
证券之星 · 07-24
7月24日常山药业跌7.98%,创业板医药ETF国泰基金重仓该股
加载更多
公司概况
公司名称:
河北常山生化药业股份有限公司
所属行业:
医药制造业
上市日期:
2011-08-19
主营业务:
河北常山生化药业股份有限公司的主营业务是肝素系列产品的研发、生产和销售。公司的主要产品是肝素钠、肝素钙、低分子量肝素钠(依诺肝素钠、达肝素钠)、低分子量肝素钙(那屈肝素钙)、透明质酸钠、枸橼酸西地那非、肝素钠注射液、低分子量肝素钙注射液、那屈肝素钙注射液、依诺肝素钠注射液、达肝素钠注射液。公司被认定为国家企业技术中心、中国创业创新典型示范企业、河北省A级研发中心、国家级高新技术企业、国家地方工程实验室、河北省多糖类药物工程技术研究中心、河北省出口名牌等。
发行价格:
28.00
{"stockData":{"symbol":"300255","market":"SZ","secType":"STK","nameCN":"常山药业","latestPrice":22.5,"timestamp":1789110222000,"preClose":22.82,"halted":0,"volume":13881084,"delay":0,"changeRate":-0.014,"floatShares":918000000,"shares":919000000,"eps":-0.3761,"marketStatus":"已收盘","change":-0.32,"latestTime":"09-11 15:00:00","open":22.58,"high":22.95,"low":22.4,"amount":314000000,"amplitude":0.0241,"askPrice":22.5,"askSize":226,"bidPrice":22.49,"bidSize":269,"shortable":0,"etf":0,"ttmEps":-0.3761,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":22.82,"symbolType":"stock","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":25.1,"lowLimit":20.54,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":919060878,"isCdr":false,"pbRate":17.66,"roa":"--","roe":"--","epsLYR":-0.39,"committee":0.438772,"marketValue":20679000000,"turnoverRate":0.0151,"status":1,"floatMarketCap":20648000000},"requestUrl":"/m/hq/s/300255","defaultTab":"news","newsList":[{"id":"2666576543","title":"常山药业(300255)股东高树华质押500万股,占总股本0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666576543","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666576543?lang=zh_cn&edition=full","pubTime":"2026-09-12 00:18","pubTimestamp":1789143507,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业9月12日公开信息显示,股东高树华向**银行股份有限公司北京分行合计质押500.0万股,占总股本0.54%。质押详情见下表:截止本公告日,股东高树华已累计质押股份1.79亿股,占其持股总数的63.86%。本文数据来源于常山药业公告,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091200000649.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0070","BK0239","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666913295","title":"常山药业(300255)披露将参加河北辖区上市公司投资者网上集体接待日暨2026年半年报业绩说明会,9月10日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666913295","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666913295?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:10","pubTimestamp":1789049427,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,常山药业报收于22.82元,较前一交易日下跌1.25%,最新总市值为209.73亿元。该股当日开盘22.92元,最高22.94元,最低22.33元,成交额达3.48亿元,换手率为1.68%。近日,常山药业披露《关于参加2026年河北辖区上市公司投资者网上集体接待日暨2026年半年报集体业绩说明会的公告》。公告显示,公司将于2026年9月16日15:30-17:00通过网络远程方式参加由河北上市公司协会、河北资本市场之家与深圳市全景网络有限公司联合举办的本次活动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000041903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0239","BK0070","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666744583","title":"股市必读:常山药业新发布《第六届董事会第九次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666744583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666744583?lang=zh_cn&edition=full","pubTime":"2026-09-09 01:00","pubTimestamp":1788886843,"startTime":"0","endTime":"0","summary":"公司公告汇总第六届董事会第九次会议决议公告河北常山生化药业股份有限公司于2026年9月7日以通讯方式召开第六届董事会第九次会议,应出席董事6名,实际出席6名,由董事长高晓东主持。董事会已审议通过授权副总经理常颜路代行总经理职责,期限自审议通过之日起至新任总经理聘任之日止;常颜路未持有公司股份,具备任职资格。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900002087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0172","300255","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872344","title":"常山药业:艾本那肽减重适应症Ⅰ期临床试验尚未完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664872344?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:48","pubTimestamp":1788439686,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,为什么阿贝那肽减重一期还不开始启动入组,拿到临床批件已经一年多了,进度为什么这么慢呢?常山药业回复:尊敬的投资者,您好!公司艾本那肽用于减重适应症的Ⅰ期临床试验,相关工作正在有序筹备中,尚未完成首例受试者入组。公司始终稳步推进相关临床试验,后续如取得重大研发进展,公司将严格按照监管规则及时履行信息披露义务。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300039678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0239","BK0070","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664873872","title":"常山药业(300255)8月31日股东户数6.34万户,较上期减少5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664873872","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664873872?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:35","pubTimestamp":1788428129,"startTime":"0","endTime":"0","summary":"证券之星消息,近日常山药业披露,截至2026年8月31日公司股东户数为6.34万户,较8月20日减少3675.0户,减幅为5.48%。在化学制药行业个股中,常山药业股东户数高于行业平均水平,截至8月31日,化学制药行业平均股东户数为3.66万户。从股价来看,2026年8月20日至2026年8月31日,常山药业区间跌幅为7.44%,在此期间股东户数减少3675.0户,减幅为5.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300031821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0070","BK0239","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664284770","title":"常山药业:公司正在根据审评要求积极稳步推进艾本那肽(阿贝那肽)的补充资料相关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2664284770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664284770?lang=zh_cn&edition=full","pubTime":"2026-09-03 08:42","pubTimestamp":1788396131,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,阿贝那肽二次技术发补,截止今天:2026年8月26日还剩26个工作日,按照此推算,最迟提交发补资料时限是10月9日。请问目前公司资料准备情况,为何还没提交发补资料,预计还需要多久?常山药业回复:尊敬的投资者,您好!公司正在根据审评要求积极稳步推进艾本那肽(阿贝那肽)的补充资料相关工作,相关资料正在有序、完善筹备中,目前尚未完成上述工作。后续相关重大进展请您关注公司将来披露的官方公告。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300007792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0172","300255","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664384770","title":"常山药业:截至2026年8月31日,公司的股东户数为63447户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664384770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664384770?lang=zh_cn&edition=full","pubTime":"2026-09-03 08:39","pubTimestamp":1788395954,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,请问截止8月31日的股东人数?常山药业回复:尊敬的投资者,您好!截至2026年8月31日,公司的股东户数为63447户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300007774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0172","300255","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731788","title":"常山药业(300255.SZ)发布上半年业绩,归母净亏损1676.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731788","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662731788?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:56","pubTimestamp":1787659001,"startTime":"0","endTime":"0","summary":"智通财经APP讯,常山药业 发布2026年半年度报告,报告期内,公司实现营业收入4.76亿元,同比下降3.21%。归属于上市公司股东净亏损1676.18万元,归属于上市公司股东的扣除非经常性损益净亏损2186.1万元。2026年上半年,公司肝素制剂产品整体销量为3,098.45万支,较上年同期增长35.89%;销售收入为27,378.78万元,同比增长17.31%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485316.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"常山药业(300255.SZ)发布上半年业绩,归母净亏损1676.18万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300255","BK0239","BK0172","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662736462","title":"常山药业(300255)披露2026年半年度报告及其摘要,8月25日股价上涨3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662736462","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662736462?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:57","pubTimestamp":1787655469,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘,常山药业报收于24.09元,较前一交易日上涨3.04%,最新总市值为221.4亿元。该股当日开盘23.16元,最高24.21元,最低22.8元,成交额达6.36亿元,换手率为2.92%。近日,河北常山生化药业股份有限公司披露《第六届董事会第八次会议决议公告》。会议应出席董事6名,实际出席6名,表决结果均为6票同意,0票反对,0票弃权。公告指出,公司2026年半年度报告真实、准确、完整地反映了经营情况,财务报告已由董事会审计委员会审议通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500040203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300255","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735363","title":"图解常山药业中报:第二季度单季净利润同比增长31.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735363","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662735363?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:19","pubTimestamp":1787653180,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业2026年中报显示,上半年度公司主营收入4.76亿元,同比下降3.21%;归母净利润-1676.18万元,同比上升42.38%;扣非净利润-2186.1万元,同比上升27.75%;其中2026年第二季度,公司单季度主营收入2.2亿元,同比下降5.66%;单季度归母净利润-2263.28万元,同比上升31.15%;单季度扣非净利润-2313.36万元,同比上升30.47%;负债率74.46%,财务费用4950.58万元,毛利率21.62%。财报数据概要请见下图:本文数据来源于常山药业2026年中报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500038903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662738266","title":"常山药业(300255)8月20日股东户数6.71万户,较上期减少4.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662738266","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662738266?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:52","pubTimestamp":1787651547,"startTime":"0","endTime":"0","summary":"证券之星消息,近日常山药业披露,截至2026年8月20日公司股东户数为6.71万户,较8月10日减少3507.0户,减幅为4.97%。在化学制药行业个股中,常山药业股东户数高于行业平均水平,截至8月20日,化学制药行业平均股东户数为3.68万户。从股价来看,2026年8月10日至2026年8月20日,常山药业区间跌幅为7.49%,在此期间股东户数减少3507.0户,减幅为4.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500037626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0172","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224102","title":"常山药业(300255)8月20日股东户数6.71万户,较上期减少4.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224102","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661224102?lang=zh_cn&edition=full","pubTime":"2026-08-24 17:33","pubTimestamp":1787564010,"startTime":"0","endTime":"0","summary":"证券之星消息,近日常山药业披露,截至2026年8月20日公司股东户数为6.71万户,较8月10日减少3507.0户,减幅为4.97%。在化学制药行业个股中,常山药业股东户数高于行业平均水平,截至8月20日,化学制药行业平均股东户数为3.66万户。从股价来看,2026年8月10日至2026年8月20日,常山药业区间跌幅为7.49%,在此期间股东户数减少3507.0户,减幅为4.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400024563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300255","BK0239","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660744604","title":"8月19日常山药业跌5.76%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660744604","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660744604?lang=zh_cn&edition=full","pubTime":"2026-08-19 17:06","pubTimestamp":1787130390,"startTime":"0","endTime":"0","summary":"证券之星消息,8月19日常山药业跌5.76%,收盘报25.02元,换手率3.8%,成交量34.83万手,成交额8.88亿元。重仓常山药业的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900029099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0172","BK0070","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659095181","title":"常山药业:截至2026年8月10日,公司的股东户数为70629户","url":"https://stock-news.laohu8.com/highlight/detail?id=2659095181","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659095181?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:54","pubTimestamp":1786582453,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至2026年8月 10日公司的股东户数是多少?谢谢常山药业回复:尊敬的投资者,您好!截至2026年8月10日,公司的股东户数为70629户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300006768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","300255","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659181054","title":"常山药业:公司正在根据审评要求积极稳步推进艾本那肽(阿贝那肽)的补充资料相关工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2659181054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659181054?lang=zh_cn&edition=full","pubTime":"2026-08-13 08:54","pubTimestamp":1786582448,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业08月12日在投资者关系平台上答复投资者关心的问题。新药NDA审评周期受多重因素影响,审评周期长短不直接等同于审评结果。公司正在根据审评要求积极稳步推进艾本那肽的补充资料相关工作,目前尚未完成上述工作,审评进度及最终结果,请以公司后续披露的官方公告为准。公司将持续跟进审评进展,后续如发生重大进展,公司将按照监管规定及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300006762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300255","BK0172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616105","title":"8月7日常山药业涨8.66%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657616105?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:48","pubTimestamp":1786092491,"startTime":"0","endTime":"0","summary":"证券之星消息,8月7日常山药业涨8.66%,收盘报28.11元,换手率8.27%,成交量75.85万手,成交额20.53亿元。重仓常山药业的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0172","300255","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656778603","title":"常山药业(300255)披露产品拟中选第十二批国家组织药品集中带量采购,8月3日股价上涨1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656778603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656778603?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:17","pubTimestamp":1785766628,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,常山药业报收于25.21元,较前一交易日上涨1.0%,最新总市值为231.7亿元。近日,河北常山生化药业股份有限公司发布《关于公司产品拟中选第十二批国家组织药品集中带量采购的公告》。公告显示,公司产品达肝素钠注射液拟中选第十二批国家组织药品集中带量采购,拟中选产品包括0.2ml:5000IU和0.3ml:7500IU两个规格,适应症涵盖治疗急性深静脉血栓、血液透析期间预防凝血、治疗不稳定型冠状动脉疾病及术后血栓预防。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","300255","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656326732","title":"常山药业:截至2026年7月31日股东户数为61797户","url":"https://stock-news.laohu8.com/highlight/detail?id=2656326732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656326732?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:27","pubTimestamp":1785742038,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业(300255)08月03日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,请问截止7月30日的股东人数常山药业回复:尊敬的投资者,您好!截至2026年7月31日,公司的股东户数为61797户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300014145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","BK0070","BK0239","300255"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656267623","title":"常山药业:正在积极推进艾本那肽补充资料工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2656267623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656267623?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:27","pubTimestamp":1785742037,"startTime":"0","endTime":"0","summary":"证券之星消息,常山药业08月03日在投资者关系平台上答复投资者关心的问题。发补资料难易程度如何?公司正在根据审评要求积极稳步推进艾本那肽的补充资料相关工作,目前尚未完成上述工作。公司将密切跟进审评进展,严格遵照监管要求及信息披露规则,及时披露后续相关重要进展,感谢您的关注!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300014143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0172","300255","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653001897","title":"7月24日常山药业跌7.98%,创业板医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653001897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653001897?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:51","pubTimestamp":1784883102,"startTime":"0","endTime":"0","summary":"证券之星消息,7月24日常山药业跌7.98%,收盘报25.25元,换手率5.25%,成交量48.16万手,成交额12.6亿元。重仓常山药业的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国泰基金的创业板医药ETF国泰。创业板医药ETF国泰的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400028953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","300255","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789273956767,"stockEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.1694},{"period":"3month","weight":-0.3624},{"period":"6month","weight":-0.4619},{"period":"1year","weight":-0.5406},{"period":"ytd","weight":-0.6377}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河北常山生化药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"63447人(较上一季度减少5.48%)","perCapita":"14463股","listingDate":"2011-08-19","address":"河北省石家庄市正定县中国(河北)自由贸易试验区正定片区高新技术产业开发区南区梦龙街71号","registeredCapital":"91906万元","survey":" 河北常山生化药业股份有限公司的主营业务是肝素系列产品的研发、生产和销售。公司的主要产品是肝素钠、肝素钙、低分子量肝素钠(依诺肝素钠、达肝素钠)、低分子量肝素钙(那屈肝素钙)、透明质酸钠、枸橼酸西地那非、肝素钠注射液、低分子量肝素钙注射液、那屈肝素钙注射液、依诺肝素钠注射液、达肝素钠注射液。公司被认定为国家企业技术中心、中国创业创新典型示范企业、河北省A级研发中心、国家级高新技术企业、国家地方工程实验室、河北省多糖类药物工程技术研究中心、河北省出口名牌等。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"常山药业,300255,常山药业股票,常山药业股票老虎,常山药业股票老虎国际,常山药业行情,常山药业股票行情,常山药业股价,常山药业股市,常山药业股票价格,常山药业股票交易,常山药业股票购买,常山药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}